15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with thromboxane b2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, Y; Fujita, T; Muta, E; Nishida, H; Sakuma, S; Tsunomori, M | 1 |
1 other study(ies) available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and thromboxane b2
| Article | Year |
|---|---|
15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonic Acid; Blood Platelets; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Free Radical Scavengers; Hydroxyeicosatetraenoic Acids; Hydroxyl Radical; Lipoxygenase; Male; Prostaglandin-Endoperoxide Synthases; Rabbits; Thromboxane B2 | 1996 |